Literature DB >> 28836104

Involvement of aberrantly expressed microRNAs in the pathogenesis of head and neck squamous cell carcinoma.

Keiichi Koshizuka1,2, Toyoyuki Hanazawa2, Takayuki Arai1, Atsushi Okato1, Naoko Kikkawa2, Naohiko Seki3.   

Abstract

MicroRNAs (miRNAs) are small noncoding RNAs that act as fine-tuners of the post-transcriptional control of protein-coding or noncoding RNAs by repressing translation or cleaving RNA transcripts in a sequence-dependent manner in cells. Accumulating evidence have been indicated that aberrantly expressed miRNAs are deeply involved in human pathogenesis, including cancers. Surprisingly, these small, single-stranded RNAs (18-23 nucleotides) have been shown to function as antitumor or oncogenic RNAs in several types of cancer cells. A single miRNA has regulating hundreds or thousands of different mRNAs, and individual mRNA has been regulated by multiple different miRNAs in normal cells. Therefore, tightly controlled RNA networks can be disrupted by dysregulated of miRNAs in cancer cells. Investigation of novel miRNA-mediated RNA networks in cancer cells could provide new insights in the field of cancer research. In this review, we focus on head and neck squamous cell carcinoma (HNSCC) and discuss current findings of the involvement of aberrantly expressed miRNAs in the pathogenesis of HNSCC.

Entities:  

Keywords:  Antitumor; Expression signature; Head and neck squamous cell carcinoma; microRNA

Mesh:

Substances:

Year:  2017        PMID: 28836104     DOI: 10.1007/s10555-017-9692-y

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  18 in total

1.  Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.

Authors:  Sho Sugawara; Yasutaka Yamada; Takayuki Arai; Atsushi Okato; Tetsuya Idichi; Mayuko Kato; Keiichi Koshizuka; Tomohiko Ichikawa; Naohiko Seki
Journal:  J Hum Genet       Date:  2018-03-14       Impact factor: 3.172

2.  Regulation of HMGB3 by antitumor miR-205-5p inhibits cancer cell aggressiveness and is involved in prostate cancer pathogenesis.

Authors:  Yasutaka Yamada; Rika Nishikawa; Mayuko Kato; Atsushi Okato; Takayuki Arai; Satoko Kojima; Kazuto Yamazaki; Yukio Naya; Tomohiko Ichikawa; Naohiko Seki
Journal:  J Hum Genet       Date:  2017-12-01       Impact factor: 3.172

3.  Molecular pathogenesis of triple-negative breast cancer based on microRNA expression signatures: antitumor miR-204-5p targets AP1S3.

Authors:  Hiroko Toda; Sasagu Kurozumi; Yuko Kijima; Tetsuya Idichi; Yoshiaki Shinden; Yasutaka Yamada; Takayuki Arai; Kosei Maemura; Takaaki Fujii; Jun Horiguchi; Shoji Natsugoe; Naohiko Seki
Journal:  J Hum Genet       Date:  2018-09-18       Impact factor: 3.172

4.  LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.

Authors:  Zhi-Wei Chang; Yong-Xu Jia; Wei-Jie Zhang; Li-Jie Song; Ming Gao; Ming-Jun Li; Rui-Hua Zhao; Jing Li; Ya-Li Zhong; Qiao-Zhi Sun; Yan-Ru Qin
Journal:  J Exp Clin Cancer Res       Date:  2018-03-12

5.  The Expression and Effection of MicroRNA-499a in High-Tobacco Exposed Head and Neck Squamous Cell Carcinoma: A Bioinformatic Analysis.

Authors:  Shi-Qi Gong; Meng Xu; Ming-Liang Xiang; Ya-Min Shan; Hao Zhang
Journal:  Front Oncol       Date:  2019-07-31       Impact factor: 6.244

6.  miR-30e-5p represses angiogenesis and metastasis by directly targeting AEG-1 in squamous cell carcinoma of the head and neck.

Authors:  Shuiting Zhang; Guo Li; Chao Liu; Shanhong Lu; Qiancheng Jing; Xiyu Chen; Hua Zheng; Huiling Ma; Diekuo Zhang; Shuling Ren; Zhe Shen; Yunyun Wang; Zhaoyi Lu; Donghai Huang; Pingqing Tan; Jie Chen; Xin Zhang; Yuanzheng Qiu; Yong Liu
Journal:  Cancer Sci       Date:  2019-12-30       Impact factor: 6.716

7.  MicroRNA-204-5p is a tumor suppressor and potential therapeutic target in head and neck squamous cell carcinoma.

Authors:  Zehang Zhuang; Pei Yu; Nan Xie; Yue Wu; Haichao Liu; Ming Zhang; Yifan Tao; Weiwang Wang; Hanqi Yin; Bin Zou; Jinsong Hou; Xiqiang Liu; Jiong Li; Hongzhang Huang; Cheng Wang
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

8.  Involvement of dual-strand of the miR-144 duplex and their targets in the pathogenesis of lung squamous cell carcinoma.

Authors:  Akifumi Uchida; Naohiko Seki; Keiko Mizuno; Shunsuke Misono; Yasutaka Yamada; Naoko Kikkawa; Hiroki Sanada; Tomohiro Kumamoto; Takayuki Suetsugu; Hiromasa Inoue
Journal:  Cancer Sci       Date:  2018-12-06       Impact factor: 6.716

9.  miR-381 Mediates the Development of Head and Neck Squamous Cell Carcinoma via Targeting STC2.

Authors:  Hai-Feng Ma; Guo-Xiao Lv; Da-Hai Zhang
Journal:  Onco Targets Ther       Date:  2020-05-21       Impact factor: 4.147

10.  Regulation of Oncogenic Targets by miR-99a-3p (Passenger Strand of miR-99a-Duplex) in Head and Neck Squamous Cell Carcinoma.

Authors:  Reona Okada; Keiichi Koshizuka; Yasutaka Yamada; Shogo Moriya; Naoko Kikkawa; Takashi Kinoshita; Toyoyuki Hanazawa; Naohiko Seki
Journal:  Cells       Date:  2019-11-28       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.